1.Dipyridamole 2.cas no.:58-32-2 3.Test:HPLC 4.Specification:USP31/BP2003/EP6 5.GMP ISO22000 KOSHER

1.Dipyridamole 2.cas no.:58-32-23.Test:HPLC4.Specification:USP31/BP2003/EP65.GMP ISO22000 KOSHER 

Efficacy:

Dipyridamole has shown to lower pulmonary hypertension without significant drop of systemic blood pressureDipyridamole inhibits formation of pro-inflammatory cytokines (MCP-1, MMP-9) in vitro and results in reduction of hsCRP in patients.Dipyridamole inhibits proliferation of smooth muscle cells in vivo and has shown to prevent AV-shunt failure in dialysis patients.Dipyridamole increases release of t-PA from brain microvascular endothelial cells

USP31/BP2003/EP6 Dipyridamole